Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A prototype lateral flow assay for detection of orthopoxviruses.

Ulaeto DO. et al, (2022), The Lancet. Infectious diseases

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses.

McNaughton AL. et al, (2022), JCI insight

Convalescent plasma donors show enhanced cross-reactive neutralising antibody response to antigenic variants of SARS-CoV-2 following immunisation.

Harvala H. et al, (2022), Transfusion

Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages.

Prince T. et al, (2022), mSphere

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Ogbe A. et al, (2022), JCI Insight, 7

SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients.

Shankar S. et al, (2022), Journal of the American Society of Nephrology : JASN

Ribavarin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.

Salam AP. et al, (2022), PLoS Negl Trop Dis, 16

Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

Tomic A. et al, (2022), Nature communications, 13

Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytes.

Gray-Rodriguez S. et al, (2022), The Journal of pathology

Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers

Dong X. et al, (2022), GigaScience, 11

Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.

Mellors J. et al, (2022), Frontiers in immunology, 13

The characterization of multiple novel paramyxoviruses highlights the diverse nature of the subfamily Orthoparamyxovirinae.

Vanmechelen B. et al, (2022), Virus evolution, 8

Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses.

Gartlan C. et al, (2022), Frontiers in immunology, 13

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models

Lambe T. et al, (2021), Communications Biology, 4

Quantification of type i interferon inhibition by viral proteins: Ebola virus as a case study

Locke M. et al, (2021), Viruses, 13

Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine

Marriott AC. et al, (2021), npj Vaccines, 6

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern

Skelly DT. et al, (2021), Nature Communications, 12

Dose-Dependent Response to Infection with Ebola Virus in the Ferret Model and Evidence of Viral Evolution in the Eye.

Watson RJ. et al, (2021), Journal of virology, 95

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Payne RP. et al, (2021), Cell

A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19.

Huo J. et al, (2021), Nature communications, 12

Load More

Include forthcoming?